Estonja - Estonjan - Ravimiamet

pro.med.cs praha a.s. - solifenatsiin - õhukese polümeerikattega tablett - 10mg 20tk; 10mg 90tk; 10mg 30tk; 10mg 100tk; 10mg 60tk; 10mg 50tk; 10mg 10tk

Estonja - Estonjan - Ravimiamet

pro.med.cs praha a.s. - solifenatsiin - õhukese polümeerikattega tablett - 5mg 30tk; 5mg 100tk; 5mg 10tk

Estonja - Estonjan - Ravimiamet

scandic pharma sia - amlodipiin - tablett - 5mg 30tk

Estonja - Estonjan - Ravimiamet

ucb pharma oy finland - tsetirisiin - õhukese polümeerikattega tablett - 10mg 90tk; 10mg 7tk; 10mg 1tk; 10mg 10tk; 10mg 5tk; 10mg 60tk; 10mg 15tk; 10mg 21tk; 10mg 45tk; 10mg 20tk

Estonja - Estonjan - Ravimiamet

les laboratoires servier - amlodipiin+indapamiid - toimeainet modifitseeritult vabastav tablett - 5mg+1,5mg 500tk; 5mg+1,5mg 60tk; 5mg+1,5mg 15tk; 5mg+1,5mg 90tk; 5mg+1,5mg 100tk; 5mg+1,5mg 30tk

Estonja - Estonjan - Ravimiamet

les laboratoires servier - amlodipiin+indapamiid - toimeainet modifitseeritult vabastav tablett - 10mg+1,5mg 60tk; 10mg+1,5mg 500tk; 10mg+1,5mg 100tk

Estonja - Estonjan - Ravimiamet

hennig arzneimittel gmbh & co. kg - tsinnarisiin+dimenhüdrinaat - tablett - 20mg+40mg 100tk; 20mg+40mg 20tk

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

cipla (eu) limited - olansapiin - schizophrenia; bipolar disorder - psühhoeptikumid - adultsolanzapine on näidustatud skisofreenia ravi. olansapiin on efektiivne, säilitades kliinilist paranemist ajal jätkamine ravi patsientidel, kes on näidanud, esialgne ravi vastuseks. olansapiin on näidustatud ravi mõõduka kuni raske maniakaalse episoodi. patsientidel, kelle maniakaalne episood on vastanud, et olansapiin-ravi, olansapiin on näidustatud kordumise ennetamiseks patsientidel, kellel on bipolaarne häire.

Estonja - Estonjan - Ravimiamet

beres pharmaceuticals ltd. - kaltsium+kolekaltsiferool - õhukese polümeerikattega tablett - 600mg+800rÜ 90tk; 600mg+800rÜ 120tk; 600mg+800rÜ 60tk; 600mg+800rÜ 30tk

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.